These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 26258565

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Evaluation of metabolic changes within the normal appearing gray and white matters in neurologically asymptomatic HIV-1-positive and HCV-positive patients: magnetic resonance spectroscopy and immunologic correlation.
    Bladowska J, Zimny A, Kołtowska A, Szewczyk P, Knysz B, Gąsiorowski J, Furdal M, Sąsiadek MJ.
    Eur J Radiol; 2013 Apr; 82(4):686-92. PubMed ID: 23246331
    [Abstract] [Full Text] [Related]

  • 3. Two patterns of cerebral metabolite abnormalities are detected on proton magnetic resonance spectroscopy in HIV-infected subjects commencing antiretroviral therapy.
    Winston A, Duncombe C, Li PC, Gill JM, Kerr SJ, Puls RL, Taylor-Robinson SD, Emery S, Cooper DA, Altair Study Group.
    Neuroradiology; 2012 Dec; 54(12):1331-9. PubMed ID: 22772471
    [Abstract] [Full Text] [Related]

  • 4. White matter damage, neuroinflammation, and neuronal integrity in HAND.
    Alakkas A, Ellis RJ, Watson CW, Umlauf A, Heaton RK, Letendre S, Collier A, Marra C, Clifford DB, Gelman B, Sacktor N, Morgello S, Simpson D, McCutchan JA, Kallianpur A, Gianella S, Marcotte T, Grant I, Fennema-Notestine C, CHARTER Group.
    J Neurovirol; 2019 Feb; 25(1):32-41. PubMed ID: 30291567
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. CSF biomarkers of monocyte activation and chemotaxis correlate with magnetic resonance spectroscopy metabolites during chronic HIV disease.
    Anderson AM, Fennema-Notestine C, Umlauf A, Taylor MJ, Clifford DB, Marra CM, Collier AC, Gelman BB, McArthur JC, McCutchan JA, Simpson DM, Morgello S, Grant I, Letendre SL, CHARTER Group.
    J Neurovirol; 2015 Oct; 21(5):559-67. PubMed ID: 26069183
    [Abstract] [Full Text] [Related]

  • 10. Neurometabolite Alterations Associated With Cognitive Performance in Perinatally HIV-Infected Children.
    Van Dalen YW, Blokhuis C, Cohen S, Ter Stege JA, Teunissen CE, Kuhle J, Kootstra NA, Scherpbier HJ, Kuijpers TW, Reiss P, Majoie CBLM, Caan MWA, Pajkrt D.
    Medicine (Baltimore); 2016 Mar; 95(12):e3093. PubMed ID: 27015179
    [Abstract] [Full Text] [Related]

  • 11. Brain metabolism and cognitive impairment in HIV infection: a 3-T magnetic resonance spectroscopy study.
    Mohamed MA, Barker PB, Skolasky RL, Selnes OA, Moxley RT, Pomper MG, Sacktor NC.
    Magn Reson Imaging; 2010 Nov; 28(9):1251-7. PubMed ID: 20688449
    [Abstract] [Full Text] [Related]

  • 12. Alterations of Brain Metabolites in Adults With HIV: A Systematic Meta-analysis of Magnetic Resonance Spectroscopy Studies.
    Dahmani S, Kaliss N, VanMeter JW, Moore DJ, Ellis RJ, Jiang X.
    Neurology; 2021 Sep 14; 97(11):e1085-e1096. PubMed ID: 34253633
    [Abstract] [Full Text] [Related]

  • 13. Proton Chemical Shift Imaging Study of the Combined Antiretroviral Therapy Impact on Neurometabolic Parameters in Chronic HIV Infection.
    Boban J, Kozic D, Turkulov V, Lendak D, Bjelan M, Semnic M, Brkic S.
    AJNR Am J Neuroradiol; 2017 Jun 14; 38(6):1122-1129. PubMed ID: 28428210
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Additive effects of HIV and chronic methamphetamine use on brain metabolite abnormalities.
    Chang L, Ernst T, Speck O, Grob CS.
    Am J Psychiatry; 2005 Feb 14; 162(2):361-9. PubMed ID: 15677602
    [Abstract] [Full Text] [Related]

  • 17. Does choice of combination antiretroviral therapy (cART) alter changes in cerebral function testing after 48 weeks in treatment-naive, HIV-1-infected individuals commencing cART? A randomized, controlled study.
    Winston A, Duncombe C, Li PC, Gill JM, Kerr SJ, Puls R, Petoumenos K, Taylor-Robinson SD, Emery S, Cooper DA, Altair Study Group.
    Clin Infect Dis; 2010 Mar 15; 50(6):920-9. PubMed ID: 20146627
    [Abstract] [Full Text] [Related]

  • 18. Effects of human immunodeficiency virus and methamphetamine on cerebral metabolites measured with magnetic resonance spectroscopy.
    Taylor MJ, Schweinsburg BC, Alhassoon OM, Gongvatana A, Brown GG, Young-Casey C, Letendre SL, Grant I, HNRC Group.
    J Neurovirol; 2007 Apr 15; 13(2):150-9. PubMed ID: 17505983
    [Abstract] [Full Text] [Related]

  • 19. HIV-associated neurodegeneration and neuroimmunity: multivoxel MR spectroscopy study in drug-naïve and treated patients.
    Boban J, Kozic D, Turkulov V, Ostojic J, Semnic R, Lendak D, Brkic S.
    Eur Radiol; 2017 Oct 15; 27(10):4218-4236. PubMed ID: 28293774
    [Abstract] [Full Text] [Related]

  • 20. HIV, vascular and aging injuries in the brain of clinically stable HIV-infected adults: a (1)H MRS study.
    Cysique LA, Moffat K, Moore DM, Lane TA, Davies NW, Carr A, Brew BJ, Rae C.
    PLoS One; 2013 Oct 15; 8(4):e61738. PubMed ID: 23620788
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.